UBS bank predicts it will become "The Biggest Drug Ever."
Let's take a trip in the wayback machine, shall we? The year was 2003. There was no Glee or RuPaul's Drag Race. The first episode of Ellen aired that September, but Ellen Degeneres wouldn't marry Portia de Rossi for another five years. There weren't fifty million pro-gay Facebook pages because there was no Facebook. There were no Trevor Project videos on YouTube because there was no YouTube. Same-sex marriage wasn't legal anywhere in the United States. So it's safe to say that when Boy Meets Boy was published that same year, author David Levithan gave the young adult genre something it was missing: a gay love story. But wait—this isn't just any gay love story. Paul and Noah have accepting friends, accepting families, an accepting high school, and a hometown so accepting that PFLAG might as well be the PTA. In other words, the two main characters being gay is no biggie—they might as well be a straight couple in a typical teen romance book. Some critics (and critical readers) felt that the world of Boy Meets Boy was unrealistically idyllic, but it's actually just Levithan writing the world the way he hoped it might be. Well okay, maybe the cheerleaders wouldn't ride into the gym on Harleys and the Quiz Bowl team wouldn't be required to actually bowl. But in his world, gay teens would be just as free to walk down the halls holding hands as straight ones. And because of books like Boy Meets Boy that feature happy, well-adjusted gay people, he probably hoped the rest of world would start to agree. There's one more period to go before school is over; Paul hopes his physics teacher will take his mind of Noah, but no dice. All he can think is "264…264…264." Yes—he's misremembering Noah's locker number, which is about to make the aforementioned complications ensue. When the bell rings, Paul shoots out of class, but he gets waylaid by Lyssa Ling, the head of the Committee on Appointing Committees. Guess what she wants? To appoint him to a committee.
Dear Fellow Investor, UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. That's 4 times bigger than Lipitor, Zoloft and Metformin... COMBINED. It's set for FDA approval in the next 90 days. We believe an FDA approval could send shares soaring 678%. Get the name of the stock here >>> "The Buck Stops Here,"
You are receiving this e-mail because you have expressed an interest in the Fіnаncіаl Education niche on one of our landing pages or sign-up forms.
This email was sent to you by Stunning Reports operator of Event Horizon LLC. . Got questions? We’ve got answers! Connect with our friendly support team to gеt the help you need, when you need it, simply send an email to [email protected]. You’ll receive a response within 24 hours.